Authors

Guo-Qiang Bi, University of Pittsburgh
Vadim Bolshakov, Harvard University
Guojun Bu, Washington University in St Louis
Catherine M. Cahill, Queen's University, Canada
Zhou-Feng Chen, Washington University in St Louis
Graham L. Collingridge, University of Bristol, UK
Robin L. Cooper, University of KentuckyFollow
Jens R. Coorssen, University of Calgary, Canada
Alaa El-Husseini, University of British Columbia, Canada
Vasco Galhardo, University of Porto, Portugal
Wen-Biao Gan, New York University
Jianguo Gu, University of Florida
Kazuhide Inoue, Kyushu University, Japan
John Isaac, National Institutes of Health
Koichi Iwata, Nihon University, Japan
Zhengping Jia, University of Toronto, Canada
Bong-Kiun Kaang, Seoul National University, Korea
Mikito Kawamata, Sapporo Medical University, Japan
Satoshi Kida, Tokyo University of Agriculture, Japan
Eric Klann, Baylor College of Medicine
Tatsuro Kohno, Niigata University, Japan
Min Li, Johns Hopkins University
Xiao-Jiang Li, Emory University
John F. MacDonald, University of Toronto, Canada
Karim Nader, McGill University, Canada
Peter V. Nguyen, University of Alberta, Canada
Uhtaek Oh, Seoul National University, Korea
Ke Ren, University of Maryland, Baltimore
John C. Roder, University of Toronto, Canada
Michael W. Salter, University of Toronto, Canada
Weihong Song, University of British Columbia, Canada
Shuzo Sugita, University of Toronto, Canada
Shao-Jun Tang, University of California Irvine
Yuanxiang Tao, Johns Hopkins University
Yu Tian Wang, University of British Columbia, Canada
Newton Woo, National Institutes of Health
Melanie A. Woodin, University of Toronto, Canada
Zhen Yan, State University of New York at Buffalo
Megumu Yoshimura, Kyushu University, Japan
Ming Xu, University of Chicago
Zao C. Xu, Indiana University
Xia Zhang, University of Saskatchewan, Canada
Mei Zhen, University of Toronto, Canada
Min Zhuo, University of Toronto, Canada

Abstract

Understanding basic neuronal mechanisms hold the hope for future treatment of brain disease. The 1st international conference on synapse, memory, drug addiction and pain was held in beautiful downtown Toronto, Canada on August 21-23, 2006. Unlike other traditional conferences, this new meeting focused on three major aims: (1) to promote new and cutting edge research in neuroscience; (2) to encourage international information exchange and scientific collaborations; and (3) to provide a platform for active scientists to discuss new findings. Up to 64 investigators presented their recent discoveries, from basic synaptic mechanisms to genes related to human brain disease. This meeting was in part sponsored by Molecular Pain, together with University of Toronto (Faculty of Medicine, Department of Physiology as well as Center for the Study of Pain). Our goal for this meeting is to promote future active scientific collaborations and improve human health through fundamental basic neuroscience researches. The second international meeting on Neurons and Brain Disease will be held in Toronto (August 29-31, 2007).

Document Type

Article

Publication Date

12-30-2006

Notes/Citation Information

Published in Molecular Pain, v. 2, article 38, p. 1-22.

© 2006 Bi et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Digital Object Identifier (DOI)

https://doi.org/10.1186/1744-8069-2-38

Funding Information

MZ is supported by grants from NINDS NS42722, the Canadian Institutes of Health Research, the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, and the Canada Research Chair.

Included in

Biology Commons

Share

COinS